Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2026-06-03 @ 3:53 AM
Study NCT ID:
NCT01515527
Status:
RECRUITING
Last Update Posted:
2025-08-07
First Post:
2012-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2011-0987
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None